Triple-negative breast cancer (TNBC) is distinguished by the absence of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [1], three pivotal receptors that substantially influence the proliferation and dissemination of breast cancer cells. Here, ERBB2 is linked to triple-negative breast carcinoma.